Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy
about
Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion InjuryNovel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of CardiologyThe Measurement of Reversible Redox Dependent Post-translational Modifications and Their Regulation of Mitochondrial and Skeletal Muscle FunctionDiabetic Cardiovascular Disease Induced by Oxidative StressCardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesMitochondria as a therapeutic target in heart failureHeart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategiesMitochondria and cardiovascular agingPathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stressMitochondrial oxidative stress in aging and healthspanQuality control systems in cardiac agingPathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implicationsFirst-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergeticsSerendipity and the discovery of novel compounds that restore mitochondrial plasticityMitochondrial dysfunction in cardiac agingTherapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathyMitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic CardiomyopathyMitochondrial injury after mechanical stretch of cortical neurons in vitro: biomarkers of apoptosis and selective peroxidation of anionic phospholipidsMitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stressRole of circulating factors in cardiac aging.Myocardial oxidative stress correlates with left ventricular dysfunction on strain echocardiography in a rodent model of sepsis.Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory SupportHeart failure with preserved ejection fraction: molecular pathways of the aging myocardiumMitochondria and arrhythmias.Reduction of early reperfusion injury with the mitochondria-targeting peptide bendaviaMitochondrial protection restores renal function in swine atherosclerotic renovascular disease.Cerebral microvascular inflammation in DOCA salt-induced hypertension: role of angiotensin II and mitochondrial superoxide.Cardiac aging: from molecular mechanisms to significance in human health and diseaseAntioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome.Harnessing the Power of Integrated Mitochondrial Biology and Physiology: A Special Report on the NHLBI Mitochondria in Heart Diseases Initiative.SS-31 attenuates TNF-α induced cytokine release from C2C12 myotubes.Caffeic acid ethanolamide prevents cardiac dysfunction through sirtuin dependent cardiac bioenergetics preservation.Aging Exacerbates Pressure-Induced Mitochondrial Oxidative Stress in Mouse Cerebral Arteries.Studies of mitochondrial and nonmitochondrial sources implicate nicotinamide adenine dinucleotide phosphate oxidase(s) in the increased skeletal muscle superoxide generation that occurs during contractile activityReduction in mitochondrial iron alleviates cardiac damage during injuryAdenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.Mitochondria-targeted antioxidant promotes recovery of skeletal muscle mitochondrial function after burn trauma assessed by in vivo 31P nuclear magnetic resonance and electron paramagnetic resonance spectroscopyAdministration of antioxidant peptide SS-31 attenuates transverse aortic constriction-induced pulmonary arterial hypertension in mice.Pharmacological Strategies to Retard Cardiovascular AgingMacrophage migration inhibitory factor plays a permissive role in the maintenance of cardiac contractile function under starvation through regulation of autophagy
P2860
Q26744639-39E02FF9-2BC5-4BA8-BDE0-A40C8614927AQ26765793-16836B7C-D7CA-4B7F-BC00-477D31797425Q26774769-E2020483-DB6F-4395-B97E-D301DEBEDB69Q26778017-1B3C0412-F88A-4D85-B7FF-5EE60B27F0A4Q27002459-158F59AD-5D4C-4CF4-BB18-FEFDC959477FQ27005632-CD01A7B1-EDAA-436C-819F-F40F25605C52Q27005955-A527CC99-F775-4449-BDD9-CB0BF2344F3CQ27011752-3AAD8A65-276E-493D-88A7-F45EE0503411Q27015633-4698356F-445C-45C0-A8A2-99AEEDF35E53Q27025099-B99F5719-466E-46FE-8B64-B1580F0C44C1Q28084341-7C71B1ED-1AA7-432D-87A5-03D10475044DQ28085102-D70D735D-0703-4F9C-82EA-C207A84AC2E8Q28383451-5817D09A-8325-4727-851A-6AE40FBC413AQ28384256-EB440450-EF60-46DD-8034-40B898A9BCC3Q28389063-B563E489-76A4-4E49-889B-6BFA8829A9BDQ28391746-8E9055F2-07F0-4732-B3A6-ECB78C3B2C1AQ28397064-F0B51E41-395C-43CF-8157-B5B2AEE845CEQ28397584-A1AF247C-D872-4A85-8303-D3961C95BFB0Q28660732-091044AA-67CD-4094-AE8A-DF92658739B8Q30234641-D9FE479B-8886-4742-8BCA-B4A99B712858Q33559115-CFA33A1F-1453-4D36-B1FE-241A0C3AFD36Q33677357-BA4915A6-6D1B-40F2-8157-809DAAAEA2EBQ33889242-CA93E693-C2A1-4A46-8390-7DBCA1CBED0AQ33896746-46B73C2E-1CF0-4393-9155-9EC763AFA899Q33919143-1329717C-14F7-48B9-9766-AC82361280B0Q34137989-6E663185-0D6B-42BC-88D5-A4E2D44CC235Q35738321-EDC079B2-E8B9-46DC-A89F-F05231D97F53Q35898648-218D90E3-4F44-4818-8ECF-EFC6CE547A07Q35931589-6A148529-0A96-4FDA-95F8-DE035757C5ECQ35951006-DEB2FB2F-9E34-42DF-BBB8-B76D2766A833Q36017207-2E1AC962-3D58-4B4D-A43F-D78D1F075141Q36081808-4E58D67B-A189-40B8-B2C2-BB1DA91B280DQ36181501-1BFBC273-66E0-4450-9CA3-F10A672D6928Q36545944-122D3E7C-A0A0-41FB-BA31-A1F2C641AC04Q36636071-E3581F02-0D25-4606-8E91-10BC5C0428D8Q36744187-448A68A7-6381-4108-8AC9-1A6747F352C1Q36860285-4D5BA32B-94CC-4992-B23C-5D586575BEA9Q36872140-F093BC2F-5E31-480E-9183-9B1EC74B491DQ36972415-18319C46-A4A1-4F39-BCE0-558F9CB91266Q37066132-2071A180-8ECF-4D42-B803-BE499D18382C
P2860
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy
@en
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.
@nl
type
label
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy
@en
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.
@nl
prefLabel
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy
@en
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.
@nl
P2093
P2860
P50
P1476
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy
@en
P2093
Hazel Szeto
Madeline Nieves-Cintrón
Vassily Kutyavin
P2860
P356
10.1016/J.JACC.2010.12.044
P407
P577
2011-05-27T00:00:00Z